Skip to main content
Premium Trial:

Request an Annual Quote

Genome BC, Investment Agriculture Foundation of BC Launch C$2M Agri-Genomics Initiative

NEW YORK — Genome British Columbia said on Thursday that it has partnered with the Investment Agriculture Foundation of BC (IAF) on a grant program focused on the use of genomics to advance food innovation and security in the Canadian province.

Through the initiative — called the Genomic Innovation for Regenerative Agriculture, Food, and Fisheries Program — Genome BC and IAF will each contribute C$1 million (US$794,432) that will be used to fund competitive grants of up to C$250,000 each for projects using genomic technologies to drive growth, competitiveness, and sustainability for British Columbia's agriculture, food, and fisheries sectors.

"This program will develop and deploy novel genomic technologies to support food security," Federica Di Palma, CSO and VP of sectors at Genome BC, said in a statement. "We will also leverage innovative genomic solutions to improve the health of crops, livestock, and ecosystems impacted by climate change."

Genome BC said that projects funded under the new program will address some of the challenges identified by the British Columbia government's Regenerative Agriculture and Agritech Network, a four-year plan launched in mid-2021 that is using agri-tech and regenerative agriculture to help benefit farmers, food system resiliency, and the environment.

Earlier this year, Genome BC was awarded C$78 million from the Canadian provincial government for genomics research.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.